Friday, November 6, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

HP Shares Face Critical Test Amid Persistent Downtrend

Robert Sasse by Robert Sasse
November 10, 2025
in Analysis, S&P 500, Tech & Software
0
HP Stock
0
SHARES
61
VIEWS
Share on FacebookShare on Twitter

HP’s stock performance continues to disappoint investors as the company struggles to reverse a significant downward trajectory. Year-to-date, the shares have declined by 15.2%, while the twelve-month performance shows an even steeper drop of nearly 30%. This weakness stands in stark contrast to broader market indicators, with the S&P 500 advancing 16.3% and the technology sector posting impressive gains of 29.3% over the same period.

Market Experts Divided on Outlook

Financial analysts remain predominantly cautious, with most maintaining “Hold” ratings on the stock. Consensus price targets range between $28.23 and $29.63, suggesting limited upside potential from current trading levels. However, beneath this apparent consensus lies significant disagreement among major financial institutions.

On October 14, HSBC upgraded HP to “Buy” with a $30 price target, citing expectations of a PC market recovery and potential benefits from Windows-10 phase-out effects. Just eight days later, JP Morgan moved in the opposite direction, downgrading from “Buy” to “Hold” despite maintaining the same $30 price objective.

Fourth Quarter Earnings Loom as Decisive Moment

All eyes turn to November 25 when HP releases its quarterly results, which will serve as a crucial test for the struggling company. The technology firm is projected to experience an 8% EPS decline for the full 2025 fiscal year. Current expectations for the fourth quarter range between $0.87 and $0.97 per share.

Should investors sell immediately? Or is it worth buying HP?

The company’s recent track record raises concerns about its ability to meet these targets. HP has missed profit forecasts in three of the last four quarterly reports. Market participants are closely monitoring the PC division’s performance and the market reception of newly introduced AI-enabled computers. Any guidance provided for fiscal year 2026 will undergo intense scrutiny.

AI Expansion Strategy Offers Glimmer of Hope

On October 13, HP announced plans to establish a new manufacturing facility and artificial intelligence research center in Saudi Arabia. The facility already produces the HP EliteDesk AI PC, representing a strategic positioning within the growing AI hardware market. The critical question remains whether this initiative can generate sufficient momentum to reverse the company’s negative trend.

Technical and Fundamental Assessment

From a technical perspective, the outlook remains pessimistic across all time horizons with a pronounced short bias. Despite the challenging technical picture, the company maintains a market capitalization of $24.20 billion and offers a dividend yield of 4.40%, which may continue to attract income-focused investors. Nevertheless, a fundamental turnaround for the equity has yet to materialize.


Disclaimer: This content is for informational purposes only and does not constitute investment advice.

Ad

HP Stock: Buy or Sell?! New HP Analysis from November 5 delivers the answer:

The latest HP figures speak for themselves: Urgent action needed for HP investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 5.

HP: Buy or sell? Read more here...

Tags: HP
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Münchener Rück Stock
Analysis

Munich Re’s Monte Carlo Warning Collides With Wall Street’s Widest Analyst Split in Years

September 7, 2026
Xiaomi Stock
Asian Markets

Xiaomi’s September Tightrope: A Foldable Counterpunch Against Apple While EV Targets Slip

September 7, 2026
Next Post
Humana Stock

Humana Shares Plunge Following Earnings Forecast Slash

Jamf Holding Stock

Jamf Faces Pivotal Moment as Earnings and Acquisition Converge

Tilray Stock

Tilray Shares Navigate Turbulent Waters Amid Mixed Signals

Recommended

indiemiconductor Stock

Indie Semiconductor Shares Face Technical Headwinds

1 year ago
BioNTech Stock

BioNTech Secures CureVac Acquisition in Landmark mRNA Deal

11 months ago
Food Retailers Market Capitalization

Victorias Secret Reports Strong Earnings Growth and Strategic Initiatives for Future Success

3 years ago

CNH Industrials Financial Report for Q4 2023 Meeting Expectations and Predicting a Slowdown in 2024

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

Pharma Pays for the Rotation While Crypto Hunts for a Floor

Tech Loses $1 Trillion, but the Rest of the Market Holds

Alphabet’s Cloud Doubles, Its Cash Turns Negative, the Stock Sinks

Margins Over Stories: Who Delivers Before the Fed and Big Tech

UPS and Coca-Cola Raise Guidance by Charging More, Not Selling More

Trending

Fastly Stock
Newsletter

Maersk Lifts Guidance a Third Time, and the Stock Still Sinks

by Stephanie Dugan
November 5, 2026
0

Dear readers, Raised guidance was supposed to be the safe harbor of earnings season. Maersk has tested...

AMD Stock

Democrats Win, and the Market Sorts Solar From Musk and Defense

November 4, 2026
Apple Stock

Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

November 3, 2026
Lumentum Stock

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

November 2, 2026
Bitcoin Stock

Pharma Pays for the Rotation While Crypto Hunts for a Floor

October 31, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Maersk Lifts Guidance a Third Time, and the Stock Still Sinks
  • Democrats Win, and the Market Sorts Solar From Musk and Defense
  • Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com